Summary
A number of recently described inherited disorders interfere with the oxidation of fatty acids. In these disorders at least three different metabolic steps may be affected: (1) transport of long chain fatty acids into the mitochondria as in carnitine deficiency and carnitine palmitoyl transferase deficiency (CPT); (2) multiple acyl CoA dehydrogenase deficiency or glutaric aciduria type I1 (GAII) due presumably to a defective common electron transfering flavoprotein or iron sulfur flavoprotein; (3) specific long or medium chain fatty acyl CoA dehydrogenase deficiency as in inherited dicarboxylic aciduria. In order to develop a system for the detection and the study of the consequences of defects such as these on the oxidation of fatty acids, we investigated the metabolism of oleate (18 carbons), octanoate (eight carbons) and butyrate (four carbons) in intact cultured fibroblasts from patients with CPT deficiency, GAII, and dicarboxylic aciduria.
In CPT deficient cells there was a markedly deficient ability to oxidize 11-14CI and [U-14C] oleate (19 and 5% of normal, respectively), whereas oxidations of [I-14C1 octanoate and [1,4-14CI succinate were significantly increased (150 and 222%, respectively), and 11-14C] butyrate oxidation was normal. GAII cells displayed a nearly complete defect in the oxidation of [l-14C] and [U-I4C1 oleate (8 and 1%, respectively), as well as of [1-14CI octanoate and 11-14CI butyrate (8 and 5% of normal, respectively). The oxidation of [1,414CI succinate by GAII cells was normal. Cells from a patient with dicarboxylic aciduria showed a significant reduction in ['4C02] production from (U-'"C] oleate (57%) and (1-14Cj octanoate (31%) and a normal oxidation of [l-'4CI oleate, 11-14CI butyrate, and [1,414CI succinate. These observations are consistent with available information on the normal metabolism of fatty acids in liver and muscle and also with the hypothesis about the molecular localization of the defects in GAII and inherited dicarboxylic aciduria. They demonstrate that intact cultured skin fibroblasts represent a reliable and convenient model for the investigation of fatty acid oxidation in man.
Speculation
Many aspects of the human acyl CoA dehydrogenases and their physiologic functions remain unknown, among them the problem of their acyl chain length specificity. Studies in cultured fibroblasts from patients with presumed mutations affecting the metabolism of fatty acids provide a means for the elucidation of these defects and at the same time give information on normal metabolic functions. It appears likely that a number of previously unrecognized defects in this area of metabolism remain to be found. The availability of a model system for their study in cultured fibroblasts should facilitate their discovery.
The oxidation of fatty acids plays a major role in energy metabolism. In peripheral tissues it provides the main source of energy during fasting. In the liver it results in production of ketone bodies and increases gluconeogenic flux by providing the acetyl CoA and the reducing equivalents (NADH) necessary for gluconeogenesis (24) . Several disorders of metabolism, both acquired and inherited, have been described in which there is defective oxidation of fatty acids. These defects occur at a number of key steps. The first is that of defective transport of long chain fatty acids into the mitochondria, as occurs in generalized (7, 9) or muscular (9, 12) carnitine deficiency, or muscular (1) or hepatic carnitine palrnitoyl transferase deficiency (CPT) (4) . The second is a generalized or multiple acyl CoA dehydrogenase deficiency .
which may be due to a defect a common electron transferring flavoprotein (ETF) (18) or ETF dehydrogenase (33) as the case may be in ethylmalonic adipic aciduria (22) or glutaric aciduria type I1 (GAII) (1 1, 31) , or secondary to the action of a toxic agent such as hypoglycin A in Jamaican vomiting sickness (35) . The third step is that of a possibly specific medium or long chain fatty acid dehydrogenase deficiency (26) as may be the case in so-called dicarboxylic aciduria (14) .
The clinical presentation in these different situations is variable. There are chronic courses with myocardiopathy and proximal myopathy and muscular accumulation of lipid droplets. There are interkittent attacks of hepatic encephaldpathy with negligible svmDtoms in between: and fatal acute courses resembling Reve's , n " 2 syndrome. A common but not obligatory feature for all is hypoketotic hypoglycemia with dicarboxylic aciduria which suggests an impairment of /3 oxidation.
In order to study the consequences of these defects on the oxidation of fatty acids we investigated the formation of ['4C02] from labeled fatty acids oleate, octanoate, and butyrate using succinate as a control in cultured fibroblasts derived from skin. In order to distinguish among the abnormalities in the transport of long chain fatty acids into the mitochondria and those of the /3-oxidation of long, medium, or short chain fatty acids, we compared the results obta&ed from cells of patients with carnitine pa&itoyl transferase deficiency, glutaric aciduria type 11, and dicarboxylic aciduria.
MATERIALS AND METHODS
Cell culture. Cultured fibroblasts derived from skin were obtained from a previously published patient with a complete deficiency of hepatic carnitine palmitoyl transferase (4), one with severe neonatal glutaric aciduria type I1 (8), and an unreported patient with congenital dicarboxylic aciduria (gift of P. Divry, Lyon, France). Five control lines were obtained from healthy children aged 1-2 years. The fibroblasts were grown in roller bottles in Eagle's minimal essential medium (MEM) (Iwine Scientific Co., Santa Ana, CA), supplemented with 10% bovine fetal calf serum (FCS), nonessential amino acids and antibiotics (penicillin 100 pg/ml, streptomycin 100 pg/ml). All assays were performed between passages 6 and 9. Monolayers of fibroblasts on roller bottles were washed with phosphate buffered saline (PBS) and trypsinized when confluent, and the cells were counted. The cells were resuspended in MEM containing 10% FCS. Between 0.5-0.75 x lo6 cells in 3 ml were put in 25 ml plastic tissue culture flasks (Corning Glass Works, Coming, NY) for 18 h to obtain monolayers for experiments on oxidation. For each experiment two to three control flasks were trypsinized and used to determine , to obtain about 1500 cpm/nanomole for octanoate and butyrate, and 200-300 cpm/nanomole for succinate. After 18 h in culture monolayers of fibroblasts were washed two times with 3 ml of PBS, and 1.5 ml of Leibovitz's medium L-15, pH 7.6 (Irvine Scientific Co., Santa Ana, CA) were put in each flask. This medium contains an arginine phosphate buffer system and does not contain bicarbonate. The reactions were initiated by adding the radioactive mixture to the incubation flasks to yield a final volume of 2 ml. The flasks were tightly closed with stoppers (Kontes, CA), and plastic center wells (Kontes, CA) were attached each containing a 3 x 3 cm piece of Whatman No. 1 filter paper. The flasks were incubated at 37°C. At the end of the incubation, 150 p1 of 1 M hyamine hydroxide (Sigma Lab., St Louis, MO) was injected onto the filter paper and the radioactive CO2 released was collected for 30 min at room temDerature without acidification of the medium. This method gave'85-95% collection of [l4CO2J and lower blank values ( t 5 0 cpm) as compared to that with acidification, (50 p1 of perchloric acid 10 M). After collection, the flasks were opened and the filter papers were placed in vials containing 10 ml scintillation fluid [0.5% 2,5 diphenyloxazole (scintillation grade) Packard in 90% toluene, 10% ethanol] and counted in a Beckrnan LS-250 scintillation spectrophotometer.
The oxidation of each radioactive substrate was tested 2-7 times. All of the assays were done in duplicate or triplicate. Statistical significance of differences obtained was assessed using Student's t test. incubation were varied to permit the logistics of the experiment and avoid the handling of large numbers of operations at once.
The oxidation of the various experimental substrates to [I4CO2] in the normal and pathologic celi lines studied are presented & ' The data expressed are the means + S.E. The number of assays is given in parentheses. The following symbols have been employed: ' Significantly different from control ( P < 0.01); significantly different from control ( P < 0.001); significantly different from glutaric aciduria type I1 (P < 0.05); and "significantly different from glutaric aciduria type I1 ( P < 0.001).
SAUDUBR AY ET AL.
Dicarboxylic aciduria. In the cells of the patient with dicarboxylic aciduria there was a significantly lower rate of 
DISCUSSION
The studies represent the development of a method for the investigation of fatty acid oxidation in man. A major principle is the use of intact cultured skin fibroblasts undergoing metabolism while still attached. The data obtained indicate that this is a reliable and convenient model and that it is capable of providing meaningful information on patients with different defects in oxidation.
In developing the method, experiments were carried out using cells suspended in phosphate buffer saline. It was found that there was a rapid decrease in the number of viable cells during the time of incubation. Less than 50% of the initial cell count were viable as tested with Trypan blue after 3 h, and after 5 h there were less than 10% viable cells. It was for this reason that the method was developed in which experiments were performed on monolayers. The special Leibovitz's L-15 medium was chosen instead of MEM because it is not a bicarbonate containing buffer which would require acidification of the medium for the release of COz (20); this permits the avoidance of the volatilization of octanoic and butyric acids, which would give high and variable blank values. Furthermore, it might be expected that an absence of bicarbonate would direct the metabolism of fatty acids towards oxidation rather than to the pathway of triglyceride synthesis, which requires exogenous Con.
The data obtained with three distinct pathologic cell lines are consistent with current knowledge of fatty acid oxidation. Long chain fatty acids mobilized from adipose tissue enter the cell and are activated to fatty acyl CoA esters by fatty acyl-CoA synthetase. Long chain fatty acyl residues are then transferred from coenzyme A to carnitine by carnitine palmitoyl transferase (CPTI) located on the outer face of the inner mitochondrial membrane. Carnitine is the obligatory carrier of long chain fatty acids across the mitochondrial membrane. Inside the mitochondria, a second carnitine palmitoyl transferase (CPT 11) bound to the inner face of the inner mitochondrial membrane catalyzes the reverse reaction, reconverting fatty acyl carnitine to fatty acyl CoA, which can then undergo /3-oxidation. In contrast to the long chain fatty acids, medium and short chain fatty acids are converted to their acyl CoA derivatives inside the mitochondria so that CPT reaction is not necessary for their oxidative catabolism (17, 23, 24) .
The finding that in CPT deficiency there is a nearly complete defect in the oxidation of [14C]-oleate whereas there is no defect in the oxidation of octanoate, butyrate, and succinate confirms the validity of this system for the systematic study of fatty acid oxidation. The difference between the mean production rates of [14C02] from [l-'4C]-oleate and [U-14C]-oleate expressed as % of control (19% and 5%, respectively) is not explained. It could be due to a rate limiting step of fatty oxidation at the level of medium chain acyl CoA dehydrogenase. It needs further studies on different pathologic cell lines to obtain additional information. The mechanism of the elevated rate of oxidation of octanoate and succinate observed in these cells is not clear, but it is a reasonable hypothesis that this reflects a compensatory mechanism for the defective oxidation of long chain fatty acids caused by the primary defect.
The process of P-oxidation within the mitochondria is considered to involve four enzymes in sequence. It requires FAD and NAD as cofactors and results in the formation of acetyl CoA. Pig liver mitochondria contain three acyl CoA dehydrogenases that may be differentiated on the basis of the ranges of their acyl chain length specificity. A long chain enzyme catalyzes reaction of compounds from C6 to >C16; a general enzyme, from C4 to C16; and a short chain enzyme, from C, to Cs (2) . Information on this issue of chain length specificity in man is not available. All the FAD-dependent acyl CoA dehydrogenases, including these three and isovaleryl, methylbutyryl, isobutyryl, and glutaryl CoA dehydrogenases require two proteins in common for electron transport from the reduced acyl CoA dehydrogenases to coenzyme Q in the electron transport chain: the electron transferring flavoprotein (ETF) and the iron sulfur flavoprotein (ETF dehydrogenase) (18, 33) . In inherited glutaric aciduria type I1 (GAII) there appears to be a generalized defect in all the FAD-dependent acyl CoA dehydrogenases as reasoned from the pattern of the urinary organic acids (13, 31, 34) and the demonstration of defective oxidation of leucine, isoleucine, valine, lysine, and butyrate in cultured fibroblasts (22, 31, 32) . A combined defect in so many dehydrogenases could result from a defect either in protein necessary for their activity or in a cofactor common to each (13, 31, 32) . Moreover there is some evidence that GAII is an heterogeneous disorder (8) . Our observations that in a patient with severe neonatal disease and glutaric aciduria type I1 there was a profound defect in the oxidation of oleate, octanoate, and butyrate provides further evidence for a generalized deficiency of the oxidation of fatty acids in this condition.
Long chain fatty acids may serve as precursors of medium and short chain dicarboxylic acids (30) . These dicarboxylic acid products are virtually absent from normal human urine. They are observed in the urine under conditions in which the /?-oxidation systems are overloaded, as in ketotic states (16, 28) and various pathologic conditions (5, 10, 21, 27) , after intake of medium chain triglycerides (25) , or when P-oxidation is impaired as in Jamaican vomiting sickness (35) , Reye syndrome (19) , carnitine and CPT deficiency (9) , and GAII (34) . These compounds are most probably formed in the liver from long chain monocarboxylic acids by primary microsomal a-oxidation to long chain dicarboxylic acids followed by mitochondrial P-oxidation (3, 29) .
In inherited dicarboxylic aciduria (15, 26, 36) patients have a urinary organic acid pattern of dicarboxylic aciduria in which adipic acid (C6), suberic acid (Ce), and sebacic acid (Clo) are excreted in large amounts along with their glycine conjugates. Short chain fatty acid excretion is not seen. The dicarboxylic aciduria is increased strikingly during fasting (36) suggesting a specific defect in fatty acid oxidation. A primary defect has been gypothesized to be localized at the long chain orgeneral acyl CoA dehydrogenase steps but this has not yet been demonstrated (15, 26) .
The finding in the cells of a patient with dicarboxylic aciduria that there is a reduction in the oxidation of [U-I4C]-oleate and ['4C]-octanoate and normal oxidation of butyrate and succinate is consistent with this hypothesis. The apparently normal oxidation of [l-'4C]-oleate has also been observed by Naylor et al., (26) , in a preliminary experiment. This suggests that at least one P-oxidation occurs normally in this condition, but only 50% of the [14C02] released by the control cells was obtained from the patient's cells when uniformly labeled oleate was used. When the data obtained in the patient with GAII were compared with those in the patient with dicarboxylic aciduria, the defect in the oxidation of [U-14C]-oleate and [l-'4C]-octanoate was significantly greater in GAII ( P < 0.001 and < 0.05 respectively). These results are consistent with the differences in the clinical severity of the two disorders. They suggest that in dicarboxylic aciduria there is a mutation which affects the function of fatty acyl CoA dehydrogenase less profoundly; however, there is almost certainly heterogeneity in ihese groups of individuals particularly in glutaric aciduria type I1 and in inherited dicarboxylic aciduria.
~urthe; studies on a wide variety of patients with these disorders should provide additional information on the molecuhr defect and help to elucidate the question of acyl chain length specificity of the human fatty acyl CoA dehydrogenases.
